Related Experiment Video

Updated: Jul 30, 2025

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

14.1K

HUNK inhibits epithelial-mesenchymal transition of CRC via direct phosphorylation of GEF-H1 and activating

Xiaoqi Han1,2,3, Siyuan Jiang4, Yinmin Gu4

  • 1Medical School of Guizhou University, Guiyang, 550025, China.

Cell Death & Disease
|May 16, 2023
PubMed

Insights

HUNK kinase inhibits colorectal cancer (CRC) metastasis by phosphorylating GEF-H1, stabilizing F-actin, and blocking epithelial-mesenchymal transition (EMT). This pathway is downregulated in metastatic CRC tissues.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Epithelial-mesenchymal transition (EMT) drives invasion and metastasis in colorectal cancer (CRC).
  • The precise molecular mechanisms regulating EMT in CRC remain incompletely understood.
  • Identifying key regulators of EMT is crucial for developing targeted therapies.

Purpose of the Study:

  • To elucidate the role of HUNK kinase in regulating EMT and metastasis in colorectal cancer.
  • To investigate the molecular mechanism by which HUNK influences CRC cell phenotypes.
  • To assess the clinical relevance of the HUNK-GEF-H1 pathway in human CRC tissues.

Main Methods:

  • In vitro kinase assays to determine HUNK's substrate specificity.
  • Cellular experiments involving HUNK and GEF-H1 manipulation in CRC cell lines.
  • Western blotting and immunofluorescence to analyze protein phosphorylation and F-actin stabilization.
  • Analysis of HUNK expression and GEF-H1 phosphorylation in patient-derived CRC tissues.

Main Results:

  • HUNK kinase directly phosphorylates GEF-H1 at serine 645 (S645).
  • Phosphorylation of GEF-H1 by HUNK activates RhoA, leading to LIMK-1/CFL-1 phosphorylation and F-actin stabilization.
  • This cascade effectively inhibits EMT and metastasis in CRC cells.
  • Both HUNK expression and GEF-H1 S645 phosphorylation are significantly downregulated in metastatic CRC tissues and correlate positively.

Conclusions:

  • HUNK acts as a suppressor of EMT and metastasis in colorectal cancer through direct phosphorylation of GEF-H1.
  • The HUNK-GEF-H1-RhoA signaling axis represents a critical regulatory pathway for CRC cell invasion.
  • Downregulation of this pathway correlates with metastatic potential, suggesting its utility as a prognostic biomarker.

More Related Videos

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

3.1K
RhoC GTPase Activation Assay09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

12.5K

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.0K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.7K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K